Occult axillary lymph node metastases are of no prognostic significance in breast cancer

被引:79
作者
Millis, RR [1 ]
Springall, R [1 ]
Lee, AHS [1 ]
Ryder, K [1 ]
Rytina, ERC [1 ]
Fentiman, IS [1 ]
机构
[1] City Hosp Nottingham, Dept Histopathol, Hedley Atkins ICRF Breast Pathol Lab, Nottingham NG5 1PB, England
关键词
occult metastases; micrometastases; carcinoma of breast; histological grade; tumour size;
D O I
10.1038/sj.bjc.6600070
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The significance of occult metastases in axillary lymph nodes in patients with carcinoma of the breast is controversial. Additional sections were cut from the axillary lymph nodes of 477 women with invasive carcinoma of the breast, in whom no metastases were seen on initial assessment of haematoxylin and eosin stained sections of the nodes. One section was stained with haematoxylin and eosin, and one using immunohistochemistry with two anti-epithelia[ antibodies (CAM5.2 and HMFG2). Occult metastases were found in 60 patients (13%). The median follow-up was 18.9 years with 153 breast cancer related deaths. There was no difference in survival between those with and those without occult metastases. Multivariate analysis, however, showed that survival was related to tumour size and histological grade. This node-negative group was compared with a second group of 202 patients who had one involved axillary node found on initial assessment of the haematoxylin and eosin sections; survival was worse in the patients in whom a nodal metastasis was found at the time of surgery. Survival was not related to the size of nodal metastases in the occult metastases and single node positive groups. Some previous studies have found a worse prognosis associated with occult metastases on univariate analysis, but the evidence that it is an independent prognostic factor on multivariate analysis is weak We believe that the cur-rent evidence does not support the routine use of serial sections or immunohistochemistry for the detection of occult metastases in the management of lymph node negative patients, but that the traditional factors of histological grade and tumour size are useful.
引用
收藏
页码:396 / 401
页数:6
相关论文
共 34 条
[1]  
[Anonymous], PATH REP BREAST CANC
[2]   Benign transport of breast epithelium into axillary lymph nodes after biopsy [J].
Carter, BA ;
Jensen, RA ;
Simpson, JF ;
Page, DL .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 113 (02) :259-265
[3]   Early distant relapse in 'node-negative' breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour [J].
Colpaert, C ;
Vermeulen, P ;
Jeuris, W ;
van Beest, P ;
Goovaerts, G ;
Weyler, J ;
Van Dam, P ;
Dirix, L ;
Van Marck, E .
JOURNAL OF PATHOLOGY, 2001, 193 (04) :442-449
[4]   Role of immunohistochemical detection of lymph-node metastases in management of breast cancer [J].
Cote, RJ ;
Peterson, HF ;
Chaiwun, B ;
Gelber, RD ;
Goldhirsch, A ;
Castiglione-Gertsch, M ;
Gusterson, B ;
Neville, AM .
LANCET, 1999, 354 (9182) :896-900
[5]   How to improve low lymph node recovery rates from axillary clearance specimens of breast cancer. A short term audit [J].
Cserni, G .
JOURNAL OF CLINICAL PATHOLOGY, 1998, 51 (11) :846-849
[6]   Axillary staging of breast cancer and the sentinel node [J].
Cserni, G .
JOURNAL OF CLINICAL PATHOLOGY, 2000, 53 (10) :733-741
[7]   PROGNOSTIC-SIGNIFICANCE OF BREAST-CANCER AXILLARY LYMPH-NODE MICROMETASTASES ASSESSED BY 2 SPECIAL TECHNIQUES - REEVALUATION WITH LONGER FOLLOW-UP [J].
DEMASCAREL, I ;
BONICHON, F ;
COINDRE, JM ;
TROJANI, M .
BRITISH JOURNAL OF CANCER, 1992, 66 (03) :523-527
[8]   PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .1. THE VALUE OF HISTOLOGICAL GRADE IN BREAST-CANCER - EXPERIENCE FROM A LARGE STUDY WITH LONG-TERM FOLLOW-UP [J].
ELSTON, CW ;
ELLIS, IO .
HISTOPATHOLOGY, 1991, 19 (05) :403-410
[9]   SAMPLE-SIZE - HOW MANY PATIENTS ARE NECESSARY [J].
FAYERS, PM ;
MACHIN, D .
BRITISH JOURNAL OF CANCER, 1995, 72 (01) :1-9
[10]  
FISHER ER, 1978, CANCER, V42, P2032, DOI 10.1002/1097-0142(197810)42:4<2032::AID-CNCR2820420453>3.0.CO